Autor: "Welkers MRA" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients.
Autorzy:: Huntjens DW; Pharmacy & Clinical Pharmacology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Dijkstra JA; Pharmacy & Clinical Pharmacology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Verwiel LN; Pharmacy & Clinical Pharmacology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Slijkhuis M; Pharmacy & Clinical Pharmacology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Elbers P; Department of Intensive Care Medicine, Laboratory for Critical Care Computational Intelligence (LCCI), Amsterdam Medical Data Science (AMDS), Amsterdam Cardiovascular Science (ACS), Amsterdam Institute for Infection and Immunity (AII), Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Welkers MRA; Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Veldkamp AI; Pharmacy & Clinical Pharmacology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Kuijvenhoven MA; Pharmacy & Clinical Pharmacology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
de Leeuw DC; Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Abdullah-Koolmees H; Pharmacy & Clinical Pharmacology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.; Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Postbus 85500, 3508 GA Utrecht, The Netherlands.; Clinical Pharmacy, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Kuipers MT; Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Bartelink IH; Pharmacy & Clinical Pharmacology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1081HV Amsterdam, The Netherlands.; Pokaż więcej
Źródło:: Pharmaceutics [Pharmaceutics] 2023 Jan 03; Vol. 15 (1). Date of Electronic Publication: 2023 Jan 03.
Typ publikacji:: Journal Article; Review

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: SARS-CoV-2 outbreaks in secondary school settings in the Netherlands during fall 2020; silent circulation.
Autorzy:: Jonker L; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands. .
Linde KJ; Institute for Risk Assessment Sciences, Utrecht University, Yalelaan 2, 3584 CM, Utrecht, The Netherlands.
de Hoog MLA; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.
Sprado R; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.
Huisman RC; Department of Viroscience, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GD, Rotterdam, The Netherlands.
Molenkamp R; Department of Viroscience, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GD, Rotterdam, The Netherlands.
Oude Munnink BB; Department of Viroscience, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GD, Rotterdam, The Netherlands.
Dohmen W; Institute for Risk Assessment Sciences, Utrecht University, Yalelaan 2, 3584 CM, Utrecht, The Netherlands.
Heederik DJJ; Institute for Risk Assessment Sciences, Utrecht University, Yalelaan 2, 3584 CM, Utrecht, The Netherlands.
Eggink D; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.
Welkers MRA; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.; Department of Medical Microbiology & Infection Prevention, Amsterdam University Medical Center, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.
Vennema H; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, The Netherlands.
Fraaij PLA; Department of Viroscience, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GD, Rotterdam, The Netherlands.; Department of Pediatrics, Subdivision Infectious Diseases and Immunology, Erasmus Medical Center-Sophia Children's Hospital, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
Koopmans MPG; Department of Viroscience, Erasmus Medical Center, Dr. Molewaterplein 50, 3015 GD, Rotterdam, The Netherlands.
Wouters IM; Institute for Risk Assessment Sciences, Utrecht University, Yalelaan 2, 3584 CM, Utrecht, The Netherlands.
Bruijning-Verhagen PCJL; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2022 Dec 26; Vol. 22 (1), pp. 960. Date of Electronic Publication: 2022 Dec 26.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*/genetics
COVID-19*/epidemiology
Humans ; Prospective Studies ; Netherlands/epidemiology ; Phylogeny ; Disease Outbreaks ; Schools

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Epidemiologic and Genomic Analysis of SARS-CoV-2 Delta Variant Superspreading Event in Nightclub, the Netherlands, June 2021.
Autorzy:: Koopsen J
van Ewijk CE
Bavalia R
Cornelissen A
Bruisten SM
de Gee F
Han AX
de Jong M
de Jong MD
Jonges M
Khawaja N
Koene FMHPA
van der Lubben M
Mikulic I
Rebers SPH
Russell CA
Schinkel J
Schreijer AJM
den Uil JA
Welkers MRA
Leenstra T; Pokaż więcej
Corporate Authors:: ARGOS consortium
Źródło:: Emerging infectious diseases [Emerg Infect Dis] 2022 May; Vol. 28 (5), pp. 1012-1016. Date of Electronic Publication: 2022 Mar 10.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
SARS-CoV-2*/genetics
Genomics ; Humans ; Netherlands/epidemiology
SCR Organism:: SARS-CoV-2 variants

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Rapid reinfection with SARS-CoV-2 variant-of-concern Alpha detected in a nurse during an outbreak at a non-covid inpatient ward: lessons learned.
Autorzy:: Koopsen J; Department of Medical Microbiology and Infection Prevention, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Dekker M; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands. .
Thung P; Department of Occupational Health and Safety, Amsterdam UMC, Amsterdam, The Netherlands.
Jonges M; Department of Medical Microbiology and Infection Prevention, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Vennema H; Centre for Infectious Disease Control, WHO COVID-19 Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Leenstra T; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.
Eggink D; Centre for Infectious Disease Control, WHO COVID-19 Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Welkers MRA; Department of Medical Microbiology and Infection Prevention, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Struijs PAA; Department of Orthopedic Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Reusken C; Centre for Infectious Disease Control, WHO COVID-19 Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
van Mansfeld R; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1118, 1081 HV, Amsterdam, The Netherlands.
de Jong MD; Department of Medical Microbiology and Infection Prevention, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Schinkel J; Department of Medical Microbiology and Infection Prevention, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Spijkerman IJB; Department of Medical Microbiology and Infection Prevention, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Pokaż więcej
Źródło:: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2021 Sep 26; Vol. 10 (1), pp. 137. Date of Electronic Publication: 2021 Sep 26.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19/*epidemiology
Reinfection/*virology
COVID-19/virology ; Cross Infection/epidemiology ; Cross Infection/virology ; Disease Outbreaks ; Guideline Adherence ; Humans ; Infection Control ; Inpatients ; Netherlands ; Nurses ; Phylogeny ; Reinfection/epidemiology ; SARS-CoV-2/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Welkers MRA"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język